Drug and Chemical Toxicology · 2022 · 12 citations · 40 references
MedicineOncologyPharmacologyApoptosisChemotherapyInflammationAnthracycline CardiotoxicityCancer Therapy-related CardiotoxicityCardiotoxicity ManagementMolecular Mechanisms Of ToxicityOxidative Stress In InflammationReactive Oxygen SpeciesAntioxidant PropertiesCholesterol-lowering EffectsHmg-coa Reductase InhibitorsHmg-coa Reductase RegulationOxidative Stress In CancerOxidative Stress InjuryOxidative Stress-induced ApoptosisRenal Toxicity Mitigation
Doxorubicin (DOXO) is a cytostatic agent used in the chemotherapy protocol of several cancers for more than 40 years, but usage of this drug in cancer treatment has been limited due to severe renal and cardiac tissue toxicities that may result in death in patients. Fluvastatin (FV) is a fully synthetic hydroxymethyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor used as a cholesterol-lowering agent in patients with hypercholesterolemia. Previous studies revealed that FV also exhibits antioxidant, anti-inflammatory, and antitumor activity. Additionally, our previous study indicated that FV exerts a prophylactic effect on DOXO-induced testicular toxicity by preventing lipid peroxidation, supporting the antioxidant system, and regulating the blood-testis barrier-associated genes expression. Herein, we purposed to evaluate the possible therapeutic and the protective effects of FV on the DOXO-induced cardiac and renal toxicitiy model by histochemical, immunohistochemical, biochemical, and real-time polymerase chain reaction (real-time PCR) analyses. Results point out protective use of FV exerts a beneficial effect by repressing lipid peroxidation and by regulating the inducible nitric oxide synthase (iNOS), nitric oxide synthase endothelial (eNOS), nuclear factor kappa-B (NF-κB), and Caspase-3 (Casp3) protein and mRNA expressions, which play an important role in mediating DOXO-induced renal and cardiac toxicity mechanisms. In conclusion, FV may be a candidate agent for the prevention of renal and cardiac toxicities in cancer patients receiving DOXO chemotherapy.
40
Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
Alexander Riad, Sandra Bien, Dirk Westermann et al. · Cancer Research · 2009 · 205 citations
Medicine, Cardiology, Pharmacology +17
Doxorubicin Induced Nephrotoxicity: Protective Effect of Nicotinamide
Şule Ayla, İsmail Seçkin, Gamze Tanrıverdi et al. · International Journal of Cell Biology · 2011 · 163 citations · Full text
Medicine, Pharmacology, Toxicology +17